Silver Book Fact

Multifoca electroretinogram (mFERG) measures show abnormal function of the retina early in–and even prior to–diabetic retinopathy onset and could enhance monitoring of the early stages of disease progression in individuals.

Bearse M, Adams A, Han Y, Schneck M, et al. A Mulifocal Electroretinogram Model Predicting the Development of Diabetic Retinopathy. Prog Retin Eye Res. 2006; 25(5): 425-448. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773701/

Reference

Title
A Mulifocal Electroretinogram Model Predicting the Development of Diabetic Retinopathy
Publication
Prog Retin Eye Res
Publication Date
2006
Authors
Bearse M, Adams A, Han Y, Schneck M, et al
Volume & Issue
Volume 25, Issue 5
Pages
425-448
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Multifoca electroretinogram (mFERG) measures show abnormal function of the retina early in–and even prior to–diabetic retinopathy onset and could enhance monitoring of the early stages of disease progression in individuals.  
  • Eye Exams: Trends, 1996-2006 (in relation to screening for diabetic retinopathy)  
  • Anti-VEGF Visual Improvement
    Nearly 50% of DME patients who received an anti-VEGF drug, experienced substantial visual improvement after a year of injections.  
  • Tele-ophthalmology
    Adequately trained general practitioners can screen for DR with 90% sensitivity using tele-ophthalmology.  
  • Supplementation with lutein increases macular pigment optical density by 27%; which is correlated with benefits in visual function.